Position in RXRX
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$32,835,862
+$17,175,067 QoQ
Shares Held
8,947,102
+75.4% QoQ
Ownership
1.67%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#10
of 344 holders
Holding Since
Jun 2021
21 quarters on record
Voting authority
Sole 98%
Shared 0%
None 2%
Common Shares in RXRX Over Time
Shares Held
Position Value (USD)
Derivatives in RXRX
reported options exposure · as of Mar 31, 2026CallValue
$132,476
CallShares
43,152
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026UBS Group AG holds $8,789,675,806 across 561 Biotechnology names. RXRX ranks #52 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RVMD |
Revolution Medicines, Inc.
|
5,450,825 | $1,020,369,609 | |
| 2 | ROIV |
Roivant Sciences Ltd.
|
17,466,641 | $618,144,423 | |
| 3 | PTGX |
Protagonist Therapeutics, Inc
|
3,399,221 | $416,676,508 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
712,259 | $353,800,411 | |
| 5 | MRNA |
Moderna, Inc.
|
4,463,211 | $312,558,664 | |
| 6 | INSM |
INSMED Inc
|
2,584,446 | $275,553,630 | |
| 7 | ABVX |
Abivax S.A.
|
1,844,918 | $245,853,771 | |
| 8 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
401,708 | $215,697,109 |
All Filings in RXRX
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $32,835,862 | 8,947,102 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $132,476 | 43,152 | Call | Defined | 2026-05-05 | |
| 2026-03-31 | $15,660,795 | 5,101,237 | Shares | Defined | 2026-05-05 | |
| 2025-12-31 | $15,100,367 | 3,692,022 | Shares | Defined | 2026-01-29 | |
| 2025-12-31 | $176,491 | 43,152 | Call | Defined | 2026-01-29 | |
| 2025-09-30 | $18,318,435 | 3,753,778 | Shares | Defined | 2025-11-13 | |
| 2025-09-30 | $917,928 | 188,100 | Call | Defined | 2025-11-13 | |
| 2025-06-30 | $23,430,784 | 4,630,590 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $29,464,145 | 5,569,782 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $20,311,398 | 3,004,645 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $5,271,076 | 799,860 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $12,367,874 | 1,649,050 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $6,704,136 | 672,431 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $6,822,241 | 691,911 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $2,621,494 | 342,679 | Shares | Defined | 2023-11-09 | |
| 2023-06-30 | $1,260,375 | 168,725 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $1,126,796 | 168,935 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $2,790,210 | 361,895 | Shares | Defined | 2023-02-08 | |
| 2022-09-30 | $196,467 | 18,465 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $40,586 | 4,986 | Shares | Defined | 2022-08-10 | |
| 2022-03-31 | $49,597 | 6,927 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $4,440,471 | 259,222 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $1,637,000 | 71,143 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $25,550 | 700 | Shares | Defined | 2021-08-13 | |
| No filing history on record for this holder in this stock. | ||||||